Szarmach H, Wroński A, Laudańska H, Niczyporuk W
Arch Immunol Ther Exp (Warsz). 1983;31(5):655-61.
Clinical studies on therapeutic effectiveness of ITCL applied as 2-3% ointment, 2% cream and 2-3% lotion were carried out. The study material included 96 patients at the age of 9-80. Of this group, 19 patients were with herpes zoster, 16 with herpes simplex, 29 with eczema complicated by secondary bacterial infection, 30 with palm and foot pustulosis, 1 patient with actinic cheilitis and 1 with varicella. The results obtained have revealed that the preparation is particularly effective in the treatment of dermatoses induced by herpes zoster and herpes simplex virus.
开展了关于将2-3%软膏、2%乳膏和2-3%洗剂形式的ITCL用于治疗的临床研究。研究对象包括96名年龄在9至80岁的患者。该组中，19例患有带状疱疹，16例患有单纯疱疹，29例患有湿疹并伴有继发性细菌感染，30例患有掌跖脓疱病，1例患有光化性唇炎，1例患有水痘。所获得的结果表明，该制剂在治疗由带状疱疹和单纯疱疹病毒引起的皮肤病方面特别有效。
